Protective links between Vitamin D, inflammatory bowel disease and colon cancer

World Journal of Gastroenterology

Volumn 22, Issue 3, 2016, Pages 933-948

  Meeker, Stacey ^a   Seamons, Audrey ^a   Maggio Price, Lillian ^a   Paik, Jisun ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Colitis; Colon cancer; Inflammation associated colon cancer; Inflammatory bowel disease; Mouse models; Vitamin D

Indexed keywords

VITAMIN D; BIOLOGICAL MARKER;

COLITIS; COLITIS ASSOCIATED COLON CANCER; COLON CANCER; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; NONHUMAN; REVIEW; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; ANIMAL; BLOOD; COLONIC NEOPLASMS; DIETARY SUPPLEMENT; HOST PATHOGEN INTERACTION; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; NUTRITIONAL STATUS; PROTECTION; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; BIOMARKERS; COLONIC NEOPLASMS; DIETARY SUPPLEMENTS; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; NUTRITIONAL STATUS; PROTECTIVE FACTORS; RISK FACTORS; SIGNAL TRANSDUCTION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84961333236     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i3.933     Document Type: Review

References (145)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281 [PMID: 17634462 DOI: 10.1056/NEJMra070553]
2. Holick MF. Vitamin D: Physiology, molecular biology, and clinical applications. 2nd ed. New York: Humana Press, 2010
3. Feldman D, Pike JW, Adams JS. Vitamin D. 3rd ed. Amsterdam, Boston: Academic Press, 2011
4. Eisman JA, Bouillon R. Vitamin D: direct effects of Vitamin D metabolites on bone: lessons from genetically modified mice. Bonekey Rep 2014; 3: 499 [PMID: 24605216 DOI: 10.1038/ bonekey.2013.233]
5. Holick MF. Optimal Vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007; 24: 1017-1029 [PMID: 18020534]
6. Brown SD, Calvert HH, Fitzpatrick AM. Vitamin D and asthma. Dermatoendocrinol 2012; 4: 137-145 [PMID: 22928069 DOI: 10.4161/derm.20434]
7. Hewer S, Lucas R, van der Mei I, Taylor BV. Vitamin D and multiple sclerosis. J Clin Neurosci 2013; 20: 634-641 [PMID: 23540892 DOI: 10.1016/j.jocn.2012.10.005]
8. Kostoglou-Athanassiou I, Athanassiou P, Lyraki A, Raftakis I, Antoniadis C. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab 2012; 3: 181-187 [PMID: 23323190 DOI: 10.1177/2042018812471070]
9. Norman AW, Frankel JB, Heldt AM, Grodsky GM. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 1980; 209: 823-825 [PMID: 6250216]
10. Lee S, Clark SA, Gill RK, Christakos S. 1,25-DihydroxyVitamin D3 and pancreatic beta-cell function: Vitamin D receptors, gene expression, and insulin secretion. Endocrinology 1994; 134: 1602-1610 [PMID: 8137721]
11. Correia LC, Sodre F, Garcia G, Sabino M, Brito M, Kalil F, Barreto B, Lima JC, Noya-Rabelo MM. Relation of severe deficiency of Vitamin D to cardiovascular mortality during acute coronary syndromes. Am J Cardiol 2013; 111: 324-327 [PMID: 23174181 DOI: 10.1016/j.amjcard.2012.10.006]
12. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012; 32: 2794-2802 [PMID: 22936341 DOI: 10.1161/ ATVBAHA.112.248039]
13. Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, Beekman AT, Smit JH, Penninx BW. The association between low Vitamin D and depressive disorders. Mol Psychiatry 2014; 19: 444-451 [PMID: 23568194 DOI: 10.1038/ mp.2013.36]
14. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and metaanalysis. Br J Psychiatry 2013; 202: 100-107 [PMID: 23377209 DOI: 10.1192/bjp.bp.111.106666]
15. Sato S, Tanino Y, Saito J, Nikaido T, Inokoshi Y, Fukuhara A, Fukuhara N, Wang X, Ishida T, Munakata M. Relationship between 25-hydroxyVitamin D levels and treatment course of pulmonary tuberculosis. Respir Investig 2012; 50: 40-45 [PMID: 22749249 DOI: 10.1016/j.resinv.2012.05.002]
16. Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted Vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142: 482-489 [PMID: 22155183 DOI: 10.1053/j.gastro.2011.11.040]
17. Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M, Holick MF. Optimal Vitamin D status for colorectal cancer prevention: A quantitative meta analysis. Am J Prev Med 2007; 32: 210-216 [PMID: 17296473 DOI: 10.1016/j.amepre.2006.11.004]
18. Guillot X, Semerano L, Saidenberg-Kermanac'h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine 2010; 77: 552-557 [PMID: 21067953]
19. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684-700 [PMID: 17721433]
20. Garland CF, Garland FC. Do sunlight and Vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 1980; 9: 227-231 [PMID: 7440046]
21. Mouli VP, Ananthakrishnan AN. Review article: Vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 125-136 [PMID: 24236989 DOI: 10.1111/apt.12553]
22. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Association between reduced plasma 25-hydroxy Vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol 2014; 12: 821-827 [PMID: 24161349 DOI: 10.1016/j.cgh.2013.10.011]
23. Wobke TK, Sorg BL, Steinhilber D. Vitamin D in inflammatory diseases. Front Physiol 2014; 5: 244 [PMID: 25071589 DOI: 10.3389/fphys.2014.00244]
24. Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am 2010; 39: 365-379, table of contents [PMID: 20511058 DOI: 10.1016/ j.ecl.2010.02.010]
25. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 2010; 321: 103-111 [PMID: 20156523 DOI: 10.1016/j.mce.2010.02.013]
26. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients 2013; 5: 2502-2521 [PMID: 23857223 DOI: 10.3390/nu5072502]
27. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of Vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014; 14: 342-357 [PMID: 24705652 DOI: 10.1038/ nrc3691]
28. Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: A review of molecular mechanisms. Biochem J 2012; 441: 61-76 [PMID: 22168439 DOI: 10.1042/BJ20110744]
29. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-1794 [PMID: 21530745 DOI: 10.1053/ j.gastro.2011.01.055]
30. Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 2012; 3: 107 [PMID: 22586430 DOI: 10.3389/ fimmu.2012.00107]
31. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology 2011; 140: 1807-1816 [PMID: 21530747 DOI: 10.1053/j.gastro.2011.01.057]
32. Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis 2015; 21: 409-418 [PMID: 25563695 DOI: 10.1097/MIB.0000000000000236]
33. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454: 436-444 [PMID: 18650914]
34. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603-1613 [PMID: 17499602 DOI: 10.1016/S0140-6736(07)60747-8]
35. Zator ZA, Cantu SM, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Pretreatment 25-hydroxyVitamin D levels and durability of anti-tumor necrosis factor-therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr 2014; 38: 385-391 [PMID: 24088707 DOI: 10.1177/01486071135 04002]
36. Yang L, Weaver V, Smith JP, Bingaman S, Hartman TJ, Cantorna MT. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients. Clin Transl Gastroenterol 2013; 4: e33 [PMID: 23594800 DOI: 10.1038/ctg.2013.1]
37. Jorgensen SP, Agnholt J, Glerup H, Lyhne S, Villadsen GE, Hvas CL, Bartels LE, Kelsen J, Christensen LA, Dahlerup JF. Clinical trial: Vitamin D3 treatment in Crohn's disease-A randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32: 377-383 [PMID: 20491740 DOI: 10.1111/j.1365-2036.2010.04355.x]
38. Raftery T, O'Sullivan M. Optimal Vitamin D levels in Crohn's disease: A review. Proc Nutr Soc 2015; 74: 56-66 [PMID: 25497215 DOI: 10.1017/S0029665114001591]
39. Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM, Maggio-Price L. Increased dietary Vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res 2014; 74: 4398-4408 [PMID: 24938764 DOI: 10.1158/0008-5472.CAN-13-2820]
40. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130: 2648-2652 [PMID: 11053501]
41. Ryz NR, Patterson SJ, Zhang Y, Ma C, Huang T, Bhinder G, Wu X, Chan J, Glesby A, Sham HP, Dutz JP, Levings MK, Jacobson K, Vallance BA. Active Vitamin D (1,25-dihydroxyVitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses. Am J Physiol Gastrointest Liver Physiol 2012; 303: G1299-G1311 [PMID: 23019194 DOI: 10.1152/ajpgi.00320.2012]
42. Hummel DM, Thiem U, Hobaus J, Mesteri I, Gober L, Stremnitzer C, Graca J, Obermayer-Pietsch B, Kallay E. Prevention of preneoplastic lesions by dietary Vitamin D in a mouse model of colorectal carcinogenesis. J Steroid Biochem Mol Biol 2013; 136: 284-288 [PMID: 22982628 DOI: 10.1016/j.jsbmb.2012.09.003]
43. Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, Delgado J, Arora A, Campbell LK, Joseph L, Hart J, Noffsinger A, Bissonnette M. A Vitamin D analogue inhibits colonic carcinogenesis in the AOM/DSS model. J Surg Res 2007; 142: 239-245 [PMID: 17574271]
44. Wan GJ, Kozma CM, Slaton TL, Olson WH, Feagan BG. Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy. J Med Econ 2014; 17: 384-393 [PMID: 24673303 DOI: 10.3111/13696998.201 4.909436]
45. Garg M, Lubel JS, Sparrow MP, Holt SG, Gibson PR. Review article: Vitamin D and inflammatory bowel disease-established concepts and future directions. Aliment Pharmacol Ther 2012; 36: 324-344 [PMID: 22686333 DOI: 10.1111/j.1365-2036.2012.05181. x]
46. Neuman MG, Nanau RM. Inflammatory bowel disease: role of diet, microbiota, life style. Transl Res 2012; 160: 29-44 [PMID: 22687961 DOI: 10.1016/j.trsl.2011.09.001]
47. Cantorna MT. Mechanisms underlying the effect of Vitamin D on the immune system. Proc Nutr Soc 2010; 69: 286-289 [PMID: 20515520 DOI: 10.1017/S0029665110001722]
48. Carlberg C, Molnár F. Vitamin D receptor signaling and its therapeutic implications: Genome-wide and structural view. Can J Physiol Pharmacol 2015; 93: 311-318 [PMID: 25741777 DOI: 10.1139/cjpp-2014-0383]
49. Matsuoka LY, Ide L, Wortsman J, MacLaughlin JA, Holick MF. Sunscreens suppress cutaneous Vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64: 1165-1168 [PMID: 3033008]
50. Cheng JB, Motola DL, Mangelsdorf DJ, Russell DW. Deorphanization of cytochrome P450 2R1: A microsomal Vitamin D 25-hydroxilase. J Biol Chem 2003; 278: 38084-38093 [PMID: 12867411 DOI: 10.1074/jbc.M307028200]
51. Zhu JG, Ochalek JT, Kaufmann M, Jones G, Deluca HF. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyVitamin D production in vivo. Proc Natl Acad Sci USA 2013; 110: 15650-15655 [PMID: 24019477 DOI: 10.1073/pnas.1315006110]
52. Ross AC. The 2011 report on dietary reference intakes for calcium and Vitamin D. Public Health Nutr 2011; 14: 938-939 [PMID: 21492489 DOI: 10.1017/S1368980011000565]
53. Bikle DD. Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014; 21: 319-329 [PMID: 24529992 DOI: 10.1016/j.chembiol.2013.12.016]
54. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-698 [PMID: 19172691 DOI: 10.1038/nri2378]
55. Dimitrov V, Salehi-Tabar R, An BS, White JH. Non-classical mechanisms of transcriptional regulation by the Vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention. J Steroid Biochem Mol Biol 2014; 144 Pt A: 74-80 [PMID: 23911725 DOI: 10.1016/j.jsbmb.2013.07.012]
56. Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC. A ChIP-seq defined genome-wide map of Vitamin D receptor binding: associations with disease and evolution. Genome Res 2010; 20: 1352-1360 [PMID: 20736230 DOI: 10.1101/ gr.107920.110]
57. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR. Molecular nature of the Vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2001; 2: 203-216 [PMID: 11705326]
58. Carlberg C, Dunlop TW. The impact of chromatin organization of Vitamin D target genes. Anticancer Res 2006; 26: 2637-2645 [PMID: 16886674]
59. Carlberg C, Molnár F. Detailed molecular understanding of agonistic and antagonistic Vitamin D receptor ligands. Curr Top Med Chem 2006; 6: 1243-1253 [PMID: 16848738]
60. Poon AH, Gong L, Brasch-Andersen C, Litonjua AA, Raby BA, Hamid Q, Laprise C, Weiss ST, Altman RB, Klein TE. Very important pharmacogene summary for VDR. Pharmacogenet Genomics 2012; 22: 758-763 [PMID: 22588316 DOI: 10.1097/ FPC.0b013e328354455c]
61. Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility. Gut 2000; 47: 211-214 [PMID: 10896912]
62. Bentley RW, Keown D, Merriman TR, Raj Krishnan M, Gearry RB, Barclay ML, Roberts RL, Day AS. Vitamin D receptor gene polymorphism associated with inflammatory bowel disease in New Zealand males. Aliment Pharmacol Ther 2011; 33: 855-856 [PMID: 21366629 DOI: 10.1111/j.1365-2036.2011.04588.x]
63. Malloy PJ, Tasic V, Taha D, Tütüncüler F, Ying GS, Yin LK, Wang J, Feldman D. Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyVitamin D-resistant rickets. Mol Genet Metab 2014; 111: 33-40 [PMID: 24246681 DOI: 10.1016/ j.ymgme.2013.10.014]
64. Huet T, Laverny G, Ciesielski F, Molnár F, Ramamoorthy TG, Belorusova AY, Antony P, Potier N, Metzger D, Moras D, Rochel N. A Vitamin D receptor selectively activated by gemini analogs reveals ligand dependent and independent effects. Cell Rep 2015; 10: 516-526 [PMID: 25620699 DOI: 10.1016/j.celrep.2014.12.045]
65. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB. Targeted ablation of the Vitamin D receptor: an animal model of Vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA 1997; 94: 9831-9835 [PMID: 9275211]
66. Khalili H, Talasaz AH, Salarifar M. Serum Vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction. Clin Res Cardiol 2012; 101: 321-327 [PMID: 22159952 DOI: 10.1007/s00392-011-0394-0]
67. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-697 [PMID: 9014768]
68. Schultz M, Butt AG. Is the north to south gradient in inflammatory bowel disease a global phenomenon? Expert Rev Gastroenterol Hepatol 2012; 6: 445-447 [PMID: 22928897 DOI: 10.1586/egh.12.31]
69. Burisch J, Jess T, Martinato M, Lakatos PL. The burden of inflammatory bowel disease in Europe. J Crohns Colitis 2013; 7: 322-337 [PMID: 23395397 DOI: 10.1016/j.crohns.2013.01.010]
70. Jørgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF. Active Crohn's disease is associated with low Vitamin D levels. J Crohns Colitis 2013; 7: e407-e413 [PMID: 23403039 DOI: 10.1016/j.crohns.2013.01.012]
71. Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011; 35: 308-316 [PMID: 21527593 DOI: 10.1177/0148607110381267]
72. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut 1985; 26: 1197-1203 [PMID: 3877663]
73. Torki M, Gholamrezaei A, Mirbagher L, Danesh M, Kheiri S, Emami MH. Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2015; 60: 3085-3091 [PMID: 26031421 DOI: 10.1007/ s10620-015-3727-4]
74. Ananthakrishnan AN, Cagan A, Gainer VS, Cai T, Cheng SC, Savova G, Chen P, Szolovits P, Xia Z, De Jager PL, Shaw SY, Churchill S, Karlson EW, Kohane I, Plenge RM, Murphy SN, Liao KP. Normalization of plasma 25-hydroxy Vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 2013; 19: 1921-1927 [PMID: 23751398 DOI: 10.1097/ MIB.0b013e3182902ad9]
75. Limketkai BN, Bayless TM, Brant SR, Hutfless SM. Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation. Aliment Pharmacol Ther 2014; 40: 508-517 [PMID: 24943863 DOI: 10.1111/apt.12845]
76. Hlavaty T, Krajcovicova A, Koller T, Toth J, Nevidanska M, Huorka M, Payer J. Higher Vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol 2014; 20: 15787-15796 [PMID: 25400464 DOI: 10.3748/wjg.v20.i42.15787]
77. Liu W, Chen Y, Golan MA, Annunziata ML, Du J, Dougherty U, Kong J, Musch M, Huang Y, Pekow J, Zheng C, Bissonnette M, Hanauer SB, Li YC. Intestinal epithelial Vitamin D receptor signaling inhibits experimental colitis. J Clin Invest 2013; 123: 3983-3996 [PMID: 23945234 DOI: 10.1172/JCI65842]
78. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of Vitamin D in cancer prevention. Am J Public Health 2006; 96: 252-261 [PMID: 16380576 DOI: 10.2105/AJPH.2004.045260]
79. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma Vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13: 1502-1508 [PMID: 15342452]
80. Giovannucci E. Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol 2009; 19: 84-88 [PMID: 18291673 DOI: 10.1016/j.annepidem.2007.12.002]
81. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of Vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930 [PMID: 21646368 DOI: 10.1210/jc.2011-0385]
82. Bruce D, Ooi JH, Yu S, Cantorna MT. Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) 2010; 235: 921-927 [PMID: 20660091]
83. Bruce D, Yu S, Ooi JH, Cantorna MT. Converging pathways lead to overproduction of IL-17 in the absence of Vitamin D signaling. Int Immunol 2011; 23: 519-528 [PMID: 21697289 DOI: 10.1093/ intimm/dxr045]
84. Cantorna MT, McDaniel K, Bora S, Chen J, James J. Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease. Exp Biol Med (Maywood) 2014; 239: 1524-1530 [PMID: 24668555 DOI: 10.1177/1535370214523890]
85. Cantorna MT, Waddell A. The Vitamin D receptor turns off chronically activated T cells. Ann N Y Acad Sci 2014; 1317: 70-75 [PMID: 24673331 DOI: 10.1111/nyas.12408]
86. Ooi JH, Chen J, Cantorna MT. Vitamin D regulation of immune function in the gut: why do T cells have Vitamin D receptors? Mol Aspects Med 2012; 33: 77-82 [PMID: 22079836 DOI: 10.1016/ j.mam.2011.10.014]
87. Khoo AL, Joosten I, Michels M, Woestenenk R, Preijers F, He XH, Netea MG, van der Ven AJ, Koenen HJ. 1,25-DihydroxyVitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology 2011; 134: 459-468 [PMID: 22044285 DOI: 10.1111/ j.1365-2567.2011.03507.x]
88. Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin d receptor and T cell function. Front Immunol 2013; 4: 148 [PMID: 23785369 DOI: 10.3389/fimmu.2013.00148]
89. Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of Vitamin D receptor KO mice. Proc Natl Acad Sci USA 2008; 105: 20834-20839 [PMID: 19095793 DOI: 10.1073/pnas.0808700106]
90. Cantorna MT, Zhao J, Yang L. Vitamin D, invariant natural killer T-cells and experimental autoimmune disease. Proc Nutr Soc 2012; 71: 62-66 [PMID: 21996367 DOI: 10.1017/S0029665111003193]
91. Ooi JH, Li Y, Rogers CJ, Cantorna MT. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfateinduced colitis. J Nutr 2013; 143: 1679-1686 [PMID: 23966330 DOI: 10.3945/jn.113.180794]
92. Bartels LE, Jørgensen SP, Bendix M, Hvas CL, Agnholt J, Agger R, Dahlerup JF. 25-Hydroxy Vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease. Inflammopharmacology 2013; 21: 177-186 [PMID: 23341164 DOI: 10.1007/s10787-012-0168-y]
93. Lyakh LA, Sanford M, Chekol S, Young HA, Roberts AB. TGFbeta and Vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J Immunol 2005; 174: 2061-2070 [PMID: 15699136]
94. Jeffery LE, Wood AM, Qureshi OS, Hou TZ, Gardner D, Briggs Z, Kaur S, Raza K, Sansom DM. Availability of 25-hydroxyVitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol 2012; 189: 5155-5164 [PMID: 23087405 DOI: 10.4049/jimmunol.1200786]
95. Flodström-Tullberg M, Bryceson YT, Shi FD, Höglund P, Ljunggren HG. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21: 634-640 [PMID: 19892538 DOI: 10.1016/j.coi.2009.09.012]
96. Martinet L, Smyth MJ. Balancing natural killer cell activation through paired receptors. Nat Rev Immunol 2015; 15: 243-254 [PMID: 25743219 DOI: 10.1038/nri3799]
97. Al-Jaderi Z, Maghazachi AA. Effects of Vitamin D3, calcipotriol and FTY720 on the expression of surface molecules and cytolytic activities of human natural killer cells and dendritic cells. Toxins (Basel) 2013; 5: 1932-1947 [PMID: 24169587 DOI: 10.3390/toxins5111932]
98. Balogh G, de Boland AR, Boland R, Barja P. Effect of 1,25(OH)(2)-Vitamin D(3) on the activation of natural killer cells: role of protein kinase C and extracellular calcium. Exp Mol Pathol 1999; 67: 63-74 [PMID: 10527758 DOI: 10.1006/exmp.1999.2264]
99. Weeres MA, Robien K, Ahn YO, Neulen ML, Bergerson R, Miller JS, Verneris MR. The effects of 1,25-dihydroxyVitamin D3 on in vitro human NK cell development from hematopoietic stem cells. J Immunol 2014; 193: 3456-3462 [PMID: 25149465 DOI: 10.4049/ jimmunol.1400698]
100. Marchiando AM, Graham WV, Turner JR. Epithelial barriers in homeostasis and disease. Annu Rev Pathol 2010; 5: 119-144 [PMID: 20078218 DOI: 10.1146/annurev.pathol.4.110807.092135]
101. Zhang YG, Wu S, Sun J. Vitamin D, Vitamin D Receptor, and Tissue Barriers. Tissue Barriers 2013; 1: [PMID: 24358453 DOI: 10.4161/tisb.23118]
102. Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, Bissonnette M, Li YC. Novel role of the Vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008; 294: G208-G216 [PMID: 17962355 DOI: 10.1152/ajpgi.00398.2007]
103. Assa A, Vong L, Pinnell LJ, Rautava J, Avitzur N, Johnson-Henry KC, Sherman PM. Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury. Inflamm Bowel Dis 2015; 21: 297-306 [PMID: 25590952 DOI: 10.1097/MIB.0000000000000282]
104. Chen SW, Wang PY, Zhu J, Chen GW, Zhang JL, Chen ZY, Zuo S, Liu YC, Pan YS. Protective effect of 1,25-dihydroxyvitamin d3 on lipopolysaccharide-induced intestinal epithelial tight junction injury in caco-2 cell monolayers. Inflammation 2015; 38: 375-383 [PMID: 25344656 DOI: 10.1007/s10753-014-0041-9]
105. Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, McLachlan SM, Adams JS, Hewison M. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology 2010; 151: 2423-2432 [PMID: 20392825]
106. Froicu M, Cantorna MT. Vitamin D and the Vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007; 8: 5[PMID: 17397543 DOI: 10.1186/1471-2172-8-5]
107. Froicu M, Zhu Y, Cantorna MT. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology 2006; 117: 310-318 [PMID: 16476050 DOI: 10.1111/ j.1365-2567.2005.02290.x]
108. Larmonier CB, McFadden RM, Hill FM, Schreiner R, Ramalingam R, Besselsen DG, Ghishan FK, Kiela PR. High Vitamin D3 diet administered during active colitis negatively affects bone metabolism in an adoptive T cell transfer model. Am J Physiol Gastrointest Liver Physiol 2013; 305: G35-G46 [PMID: 23639807 DOI: 10.1152/ajpgi.00065.2013]
109. Glenn AJ, Fielding KA, Chen J, Comelli EM, Ward WE. Longterm Vitamin D3 supplementation does not prevent colonic inflammation or modulate bone health in IL-10 knockout mice at young adulthood. Nutrients 2014; 6: 3847-3862 [PMID: 25247786 DOI: 10.3390/nu6093847]
110. Harris DM, Go VL. Vitamin D and colon carcinogenesis. J Nutr 2004; 134: 3463S-3471S [PMID: 15570055]
111. Akhter J, Chen X, Bowrey P, Bolton EJ, Morris DL. Vitamin D3 analog, EB1089, inhibits growth of subcutaneous xenografts of the human colon cancer cell line, LoVo, in a nude mouse model. Dis Colon Rectum 1997; 40: 317-321 [PMID: 9118747]
112. Huerta S, Irwin RW, Heber D, Go VL, Koeffler HP, Uskokovic MR, Harris DM. 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse. Cancer Res 2002; 62: 741-746 [PMID: 11830528]
113. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1 alpha,25-dihydroxyVitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005; 35: 217-224 [PMID: 15593122 DOI: 10.1002/ eji.200425491]
114. Li B, Baylink DJ, Walter MH, Lau KH, Meng X, Wang J, Cherkas A, Tang X, Qin X. Targeted 25-hydroxyVitamin D3 1-hydroxylase adoptive gene therapy ameliorates dss-induced colitis without causing hypercalcemia in mice. Mol Ther 2015; 23: 339-351 [PMID: 25327179 DOI: 10.1038/mt.2014.201]
115. Strauch UG, Obermeier F, Grunwald N, Dunger N, Rath HC, Scholmerich J, Steinmeyer A, Zugel U, Herfarth HH. Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype. World J Gastroenterol 2007; 13: 6529-6537 [PMID: 18161923 DOI: 10.3748/wjg.v13.i48.6529]
116. Zhu T, Liu TJ, Shi YY, Zhao Q. Vitamin D/VDR signaling pathway ameliorates 2,4,6-trinitrobenzene sulfonic acidinduced colitis by inhibiting intestinal epithelial apoptosis. Int J Mol Med 2015; 35: 1213-1218 [PMID: 25813397 DOI: 10.3892/ ijmm.2015.2150]
117. Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, Li C, Shih DQ, Zhang X. Protective role of 1,25(OH)2 Vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012; 12: 57[PMID: 22647055 DOI: 10.1186/1471-230X-12-57]
118. Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG. Actions of Vitamin D are mediated by the TLR4 pathway in inflammationinduced colon cancer. J Steroid Biochem Mol Biol 2010; 121: 403-407 [PMID: 20214986]
119. Lu R, Wu S, Xia Y, Sun J. The Vitamin D Receptor, Inflammatory Bowel Diseases, and Colon Cancer. Curr Colorectal Cancer Rep 2012; 8: 57-65 [PMID: 23814529 DOI: 10.1007/s11888-011-0114-1]
120. Klampfer L. Vitamin D and colon cancer. World J Gastrointest Oncol 2014; 6: 430-437 [PMID: 25400874 DOI: 10.4251/wjgo. v6.i11.430]
121. Wallace KL, Zheng LB, Kanazawa Y, Shih DQ. Immunopathology of inflammatory bowel disease. World J Gastroenterol 2014; 20: 6-21 [PMID: 24415853 DOI: 10.3748/wjg.v20.i1.6]
122. Hernandez GA, Appleyard CB. Bacterial load in animal models of acute and chronic 'ereactivated' colitis. Digestion 2003; 67: 161-169 [PMID: 12853728 DOI: 10.1159/000071296]
123. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, Jobin C. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012; 338: 120-123 [PMID: 22903521 DOI: 10.1126/science.1224820]
124. Lepage P, Hasler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S, Kupcinskas L, Dore J, Raedler A, Schreiber S. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011; 141: 227-236 [PMID: 21621540 DOI: 10.1053/j.gastro.2011.04.011]
125. Paik J, Fierce Y, Treuting PM, Brabb T, Maggio-Price L. Highfat diet-induced obesity exacerbates inflammatory bowel disease in genetically susceptible Mdr1a-/-male mice. J Nutr 2013; 143: 1240-1247 [PMID: 23761644 DOI: 10.3945/jn.113.174615]
126. Craven B, Zaric V, Martin A, Mureau C, Egan LJ. Effect of genetic deletion or pharmacological antagonism of tumor necrosis factor alpha on colitis-associated carcinogenesis in mice. Inflamm Bowel Dis 2015; 21: 485-495 [PMID: 25581824 DOI: 10.1097/ MIB.0000000000000303]
127. Huang DC, Papavasiliou V, Rhim JS, Horst RL, Kremer R. Targeted disruption of the 25-hydroxyVitamin D3 1alphahydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyVitamin D3 suppresses growth and induces differentiation in an autocrine fashion. Mol Cancer Res 2002; 1: 56-67 [PMID: 12496369]
128. de Wouters T, Dore J, Lepage P. Does our food (environment) change our gut microbiome ('ein-vironment'): A potential role for inflammatory bowel disease? Dig Dis 2012; 30 Suppl 3: 33-39 [PMID: 23295690 DOI: 10.1159/000342595]
129. Damman CJ, Miller SI, Surawicz CM, Zisman TL. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012; 107: 1452-1459 [PMID: 23034604 DOI: 10.1038/ajg.2012.93]
130. Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol 2013; 34: 1285-1300 [PMID: 23397545 DOI: 10.1007/s13277-013-0684-4]
131. Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, Brigidi P. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 2014; 20: 908-922 [PMID: 24574765 DOI: 10.3748/wjg.v20.i4.908]
132. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driverpassenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012; 10: 575-582 [PMID: 22728587 DOI: 10.1038/nrmicro2819]
133. Haller D. Nutrigenomics and IBD: The intestinal microbiota at the cross-road between inflammation and metabolism. J Clin Gastroenterol 2010; 44 Suppl 1: S6-S9 [PMID: 20535026 DOI: 10.1097/MCG.0b013e3181dd8b76]
134. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785 [PMID: 17699621 DOI: 10.1073/pnas.0706625104]
135. Bartley J. Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther 2010; 8: 1359-1369 [PMID: 21133662 DOI: 10.1586/eri.10.102]
136. Jin D, Wu S, Zhang YG, Lu R, Xia Y, Dong H, Sun J. Lack of Vitamin D Receptor Causes Dysbiosis and Changes the Functions of the Murine Intestinal Microbiome. Clin Ther 2015; 37: 996-1009. e7 [PMID: 26046242 DOI: 10.1016/j.clinthera.2015.04.004]
137. Wu S, Zhang YG, Lu R, Xia Y, Zhou D, Petrof EO, Claud EC, Chen D, Chang EB, Carmeliet G, Sun J. Intestinal epithelial Vitamin D receptor deletion leads to defective autophagy in colitis. Gut 2015; 64: 1082-1094 [PMID: 25080448 DOI: 10.1136/ gutjnl-2014-307436]
138. Wu S, Yoon S, Zhang YG, Lu R, Xia Y, Wan J, Petrof EO, Claud EC, Chen D, Sun J. Vitamin D receptor pathway is required for probiotic protection in colitis. Am J Physiol Gastrointest Liver Physiol 2015; 309: G341-G349 [PMID: 26159695 DOI: 10.1152/ ajpgi.00105.2015]
139. Zh a n g H, Wu H, Li u L, Li H, S h i h DQ, Zh a n g X. 1,25-dihydroxyVitamin D3 regulates the development of chronic colitis by modulating both T helper (Th)1 and Th17 activation. APMIS 2015; 123: 490-501 [PMID: 25907285 DOI: 10.1111/ apm.12378]
140. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324: 23-33 [PMID: 17911375 DOI: 10.1124/jpet.107.127209]
141. Knackstedt RW, Moseley VR, Sun S, Wargovich MJ. Vitamin D receptor and retinoid X receptor status and Vitamin D insufficiency in models of murine colitis. Cancer Prev Res (Phila) 2013; 6: 585-593 [PMID: 23585425 DOI: 10.1158/1940-6207.CAPR-12-0488]
142. Golan MA, Liu W, Shi Y, Chen L, Wang J, Liu T, Li YC. Transgenic Expression of Vitamin D Receptor in Gut Epithelial Cells Ameliorates Spontaneous Colitis Caused by Interleukin-10 Deficiency. Dig Dis Sci 2015; 60: 1941-1947 [PMID: 25894930 DOI: 10.1007/s10620-015-3634-8]
143. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the Vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 2003; 17: 2386-2392 [PMID: 14500760 DOI: 10.1210/me.2003-0281me.2003-0281]
144. Chen J, Bruce D, Cantorna MT. Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol 2014; 15: 6 [PMID: 24502291 DOI: 10.1186/1471-2172-15-6]
145. Dougherty U, Mustafi R, Sadiq F, Almoghrabi A, Mustafi D, Kreisheh M, Sundaramurthy S, Liu W, Konda VJ, Pekow J, Khare S, Hart J, Joseph L, Wyrwicz A, Karczmar GS, Li YC, Bissonnette M. The renin-angiotensin system mediates EGF receptorvitamin d receptor cross-talk in colitis-associated colon cancer. Clin Cancer Res 2014; 20: 5848-5859 [PMID: 25212605 DOI: 10.1158/1078-0432.CCR-14-0209]